Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedem

Clinical and Experimental Immunology

Volumn 106, Issue 3, 1996, Pages 475-480

  Cicardi, M ^a   Beretta, A ^a   Colombo, M ^a   Gioffre D ^a   Cugno, M ^a   Agostoni, A ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Istituto di Medicina Interna   (Italy)

Author keywords

Acquired angio oedema; Autoantibodies; C1 inhibitor; Lymphoproliferative disease

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1S INHIBITOR; PARAPROTEIN;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL;

EID: 0029851034     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-866.x     Document Type: Article

References (33)

1. Caldwell JR, Ruddy S, Schur PH et al. Acquired Cl inhibitor deficiency in lymposarcoma. Clin Immunol Immunopathol 1972; 1:39-52.
2. Gelfand JA, Boss GR, Conley CL et al. Acquired Cl esterase inhibitor deficiency and angioedema: a review. Medicine (Baltimore) 1979; 58:321-8.
3. Cicardi M, Frangi D, Bergamaschini L et al. Acquired Cl inhibitor deficiency with angioedema symptoms in a patient with Echinococcus granulosus. Complement 1985; 2:133-9.
4. Sheffer AL, Austen KF, Rosen FS et al. Acquired deficiency of the inhibitor of the first component of complement: report of five additional cases with commentary on the syndrome. J Allergy Clin Immunol 1985; 75:640 6.
5. Pascual M, Widmann JJ, Schifferli JA. Recurrent febrile panniculitis and hepatitis in two patients with acquired complement deficiency and paraproteinemia. Am J Med 1987; 83:959 62.
6. Nakamura S, Yoshinari M, Saku Y et al. Acquired Cl inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system. Ann Rheum Dis 1991; 50:713 6.
7. Frigas E. Angioedema with acquired deficiency of Cl inhibitor: a constellation of syndromes. Mayo Clin Proc 1989; 64:1269 75.
8. Jackson J, Sim RB, Whelan A et al. An IgG autoantibody which inactivates Cl-inhibitor. Nature 1986; 323:722 4.
9. Alsenz J, Bork K, Loos M. Autoantibody-mediated acquired deficiency of Cl inhibitor. N Engl J Med 1987; 316:1360 6.
10. Frank MM, Malbran A, Simms H et al. Acquired angioedema type II (AAE-II). A new autoimmune disease [Abstr.]. Clin Res 1987; 35:641.
11. Späth PJ, Wüthrich B, Matter L et al. Acquired angioedema and anti-Cl-inhibitor autoantibody. Arch Intern Med 1989; 149:1213 4.
12. Zuraw BL, Altman LC. Acute consumption of Cl inhibitor with acquired Cl-inhibitor deficiency syndrome. J Allergy Clin Immunol 1991; 88:908 18.
13. Donaldson VH, Bernstein DI, Wagner CJ et al. Angioneurotic oedema with acquired Cl inhibitor deficiency and autoantibody to Cl inhibitor: response to plasmapheresis and cytotoxic therapy. J Lab Clin Med 1992; 119:397-406.
14. Cicardi M, Bisiani G, Cugno M et al. Autoimmune Cl inhibitor deficiency: report of eight patients. Am J Med 1993; 95:169 75.
15. Boyar A, Zuraw B, Beall G. Immunoadsorption in acquired angioedema: a therapeutic misadventure. Clin Immunol Immunopathol 1993; 66:181 3.
16. Mandle R, Baron C, Roux E et al. Acquired Cl inhibitor deficiency as a result of an autoantibody to the reactive center region of Cl inhibitor. J Immunol 1994; 152:4680-5.
17. Wasserfallen JB, Späth P, Guillou L et al. Acquired deficiency in Cl-inhibitor associated with signet ring cell gastric adenocarcinoma: a probable connection of antitumor-associated antibodies, hemolytic anemia, complement turnover. J Allergy Clin Immunol 1995; 95:124-31.
18. Geha RS, Quinti I, Austen KF et al. Acquired Cl-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins. N Engl J Med 1985; 312:534-40.
19. Zuraw BL, Curd JG. Demonstration of modified inactive first component of complement (Cl) inhibitor in the plasmas of Cl-inhibitor-deficient patients. J Clin Invest 1986; 78:567 75.
20. Jackson J, Feighery C. Autoantibody-mediated acquired deficiency of Cl inhibitor. N Engl J Med [Letter] 1987; 318:123 4.
21. Alsenz J, Bork K, Loos M. Autoantibody-mediated acquired deficiency of Cl inhibitor. N Engl J Med [Letter] 1987; 318:124.
22. Malbran A, Hammer CH, Frank MM et al. Acquired angioedema: observations on the mechanism of action of autoantibodies directed against Cl esterase inhibitor. J Allergy Clin Immunol 1988; 81:1199-204.
23. Jackson J, Sim RB, Whaley K et al. Autoantibody facilitated cleavage of Cl inhibitor in autoimmune angioedema. J Clin Invest 1989;83:698-707.
24. Alsenz J, Lambris JD, Bork K et al. Acquired Cl inhibitor (Cl INH) deficiency type II. J Clin Invest 1989; 83:1794-99.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 1970; 227:680-5.
26. Katskis PD, Pavlidis NA, Papadopoulos NM et al. Monoclonal immunoglobulins and autoantibodies in lymphoid malignancies. Anticancer Res 1990; 10:1719 24.
27. Duggan DB, Schattner A. Unusual manifestations of monoclonal gammopathies. Autoimmune and idiopathic syndromes. Am J Med 1986; 81:864 70.
28. Schroeder HW, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994; 15:288-94.
29. He S, Tsang S, North J et al. Epitope mapping of Cl inhibitor autoantibodies from patients with acquired Cl inhibitor deficiency. J Immunol 1996; 156:2009 13.
30. Chevallier A, Arlaud G, Ponard D et al. C1-inhibitor binding monoclonal immunoglobulins in three patients with acquired angioneurotic edema. J Allergy Clin Immunol 1996; 97:998-1008.
31. Hole ER, Whaley K. Monoclonal antibodies to Cl-inhibitor in acquired angio-oedema. Complement Inflamm 1990; 7:144.
32. Schreiber AD, Zweiman B, Atkins P et al. Acquired angioedema with lymphoproliferative disorder: association of Cl-inhibitor deficiency with cellular abnormality. Blood 1976; 48:567 80.
33. Shoenfeld Y. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 1994; 8:1296 301.